Sign in →

Test Code LAB102 Low-Density Lipoprotein (LDL) Cholesterol, Beta-Quantification, Serum

Additional Codes

DIR LDL

Reporting Name

LDL Cholesterol (Beta-Quant), S

Useful For

Evaluation of cardiovascular risk

 

Verification of estimated low-density lipoprotein cholesterol (LDL-C) in patients with hypertriglyceridemia or extremely low LDL-C

 

Diagnosis of familial hypobetalipoproteinemia and abetalipoproteinemia


Necessary Information


Indicate patient's age and sex.



Specimen Required


Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 3 mL

Collection Instructions: Centrifuge and aliquot serum into plastic vial. Send refrigerated.


Seattle Children's Hospital Note:

Collect 6.0 mL whole blood in a Red top.

Specimen Type

Serum

Specimen Minimum Volume

2 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 10 days
  Frozen  60 days

Day(s) Performed

Monday through Thursday; Saturday, Sunday

Seattle Children's Hospital Note:

TAT: 4 - 6 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Method Name

Ultracentrifugation/Selective Precipitation/Enzymatic Colorimetric

Method Description

Serum is combined with dextran sulfate and magnesium, ions precipitate the low-density lipoprotein and very low-density lipoprotein fractions, leaving the high-density lipoprotein (HDL) fraction in solution. The HDL cholesterol is then determined using an enzymatic cholesterol assay.(Package insert: HDL Cholesterol Precipitating Reagent Set [Dextran Sulfate]; Pointe Scientific, Inc; 12/2009)

 

Cholesterol esters are cleaved by the action of cholesterol esterase to yield free cholesterol and fatty acids. Cholesterol oxidase then catalyzes the oxidation of cholesterol to cholest-4-en-3-one and hydrogen peroxide. In the presence of peroxidase, the hydrogen peroxide formed effects the oxidative coupling of phenol and 4-aminophenazone to form a red quinone-imine dye. The color intensity of the dye formed is directly proportional to the cholesterol concentration. It is determined by measuring the increase in absorbance.(Package insert: Cholesterol Gen2 Reagent. Roche Diagnostics; V 16.0, 10/2023)

Reference Values

The National Lipid Association and the National Cholesterol Education Program (NCEP) have set the following guidelines for LDL-C in adults (ages 18 years and up):

Desirable: <100 mg/dL

Above desirable: 100-129 mg/dL

Borderline high: 130-159 mg/dL

High: 160-189 mg/dL

Very high: ≥190 mg/dL

 

The Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents has set the following guidelines for LDL-C in children and adolescents (ages 2-17 years):

Acceptable: <110 mg/dL

Borderline high: 110-129 mg/dL

High: ≥130 mg/dL

Test Classification

This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

83701

LOINC Code Information

Test ID Test Order Name Order LOINC Value
LDLD LDL Cholesterol (Beta-Quant), S 18261-8

 

Result ID Test Result Name Result LOINC Value
LDLC LDL Chol (Beta-Quantification), S 18261-8

Report Available

2 to 4 days

Reject Due To

Gross hemolysis Reject
Gross lipemia OK
Gross icterus Reject

Forms

If not ordering electronically, complete, print, and send a Cardiovascular Test Request Form (T724) with the specimen.

Seattle Children's Hospital Additional Information:

Aliases: Beta Quantification LDL; Cholesterol in Low-Density Lipoproteins (LDL); Cholesterol, DLD (Low-Density Lipoprotein); Direct LDL (Low-Density Lipoprotein); LDL (Low-Density Lipoprotein) Cholesterol; LDL Cholesterol (LDLC); LDL Cholesterol (order if only LDL indicated); LDL Direct; Low (Low-Density Lipoprotein) Direct; Low-Density Lipoprotein (LDL); Soft-LDLD; Beta Quant LDL; Abetalipoproteinemia; Hypolipoproteinemia; Familial hypercholesterolemia (FH); Type III hyperlipoproteinemia/dysbetalipoproteinemia